NCTX

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameNCTX
Drug Alias Namepegylated iodixanol (Marval)iodine based CT agent (Marval)NCTX
ClassificationOther
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsWounds and InjuriesCardiovascular DiseasesRenal Insufficiency +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMarval Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMarval Biosciences Inc
Active IndicationsN/A
Inactive IndicationsWounds and InjuriesCardiovascular DiseasesRenal Insufficiency +[4

Other Information

ATC CodeN/A
Related LinksN/A